Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Novo Nordisk (NVO) Declines More Than Market: Some Information for Investors
06:45pm, Wednesday, 22'nd Oct 2025
Novo Nordisk (NVO) closed at $53.38 in the latest trading session, marking a -2.56% move from the prior day.
NVO Stock Falls Amid Governance Shift as Foundation Seeks New Board
12:06pm, Wednesday, 22'nd Oct 2025
Novo Nordisk stock slides as the Novo Nordisk Foundation pushes a sweeping board overhaul, signaling a new era in governance and strategic direction.
Evening digest: Trump-Putin talks are stalled, Sarkozy begins prison term, gold crashes
12:00pm, Wednesday, 22'nd Oct 2025
A tense day in global politics and markets: the Trump-Putin summit is in limbo after Moscow refused a Ukraine ceasefire. France's former president Nicolas Sarkozy has begun a historic prison term, gol
Novo Nordisk shares fall as top investor drives board overhaul
04:40am, Wednesday, 22'nd Oct 2025
Shares in Novo Nordisk fell around 3% in early trading on Wednesday, extending their losses from a day earlier, after the Wegovy maker's top investor proposed a sweeping board overhaul.
Novo Nordisk chairman and six board members to step down following governance dispute
04:16pm, Tuesday, 21'st Oct 2025
Novo Nordisk (NYSE:NVO)said on Tuesday that its chairman, Helge Lund, and six other independent board members will resign following a dispute with the company's largest shareholder, the Novo Nordisk F
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill
03:27pm, Tuesday, 21'st Oct 2025
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.
Who's on Novo Nordisk's board after major shakeup?
12:40pm, Tuesday, 21'st Oct 2025
Novo Nordisk will replace chair Helge Lund and six independent directors next month in a major boardroom shakeup following a disagreement over strategy with its powerful controlling shareholder, Novo
HSBC's Rajesh Kumar on Novo Nordisk: We want to see management team execute turnaround strategy
12:36pm, Tuesday, 21'st Oct 2025
Rajesh Kumar, HSBC Sr. health care analyst, joins CNBC's 'Money Movers' to discuss his reaction to a board shakeup at Novo Nordisk.
Novo Nordisk's Entire Board Is Stepping Down. Here's Why.
12:28pm, Tuesday, 21'st Oct 2025
The board turmoil represents a breakdown in relations between the company and its controlling shareholder.
Novo Nordisk A/S (NVO) Discusses Extraordinary General Meeting on Proposed Board Changes and Governance Transcript
12:04pm, Tuesday, 21'st Oct 2025
Novo Nordisk A/S (NVO) Discusses Extraordinary General Meeting on Proposed Board Changes and Governance October 21, 2025 9:00 AM EDT Company Participants Jacob Martin Rode - Head of Investor Relations
NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients
10:31am, Tuesday, 21'st Oct 2025
Novo Nordisk secures FDA approval for Rybelsus as the first oral GLP-1 therapy proven to cut major heart risks in adults with type II diabetes.
Novo Nordisk to Replace Chairman and Other Board Members
08:59am, Tuesday, 21'st Oct 2025
An extraordinary meeting will take place next month to vote on new members after the company and its controlling shareholder failed to agree on the board's composition.
The Ozempic maker shakes up its board. It has been a year of turmoil for Novo Nordisk.
08:54am, Tuesday, 21'st Oct 2025
Ozempic maker Novo Nordisk is shaking up its board.
Novo Nordisk in active talks with Trump administration on MFN
08:40am, Tuesday, 21'st Oct 2025
Novo Nordisk U.S. President Dave Moore confirms the company is in active discussions with the Trump administration over most favored nation pricing for its popular GLP-1 drugs Ozempic and Wegovy, as i
Novo Nordisk board members step down after clash with controlling shareholder
08:40am, Tuesday, 21'st Oct 2025
Novo Nordisk directors and the firm's controlling shareholder failed to reach an agreement on the future composition of the board.
